144 related articles for article (PubMed ID: 38227062)
41. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
42. Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery.
Chai F; Wang Y; Zhou Y; Liu Y; Geng D; Liu J
Obes Surg; 2011 Jun; 21(6):768-73. PubMed ID: 21240658
[TBL] [Abstract][Full Text] [Related]
43. The effect of aging on glucose metabolism improvement after Roux-en-Y gastric bypass in type 2 diabetes rats.
Chen W; Yin H; Xiao J; Liu W; Qu Q; Gong F; He X
Nutr Diabetes; 2022 Dec; 12(1):51. PubMed ID: 36564376
[TBL] [Abstract][Full Text] [Related]
44. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
[TBL] [Abstract][Full Text] [Related]
45. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?
Dar MS; Chapman WH; Pender JR; Drake AJ; O'Brien K; Tanenberg RJ; Dohm GL; Pories WJ
Obes Surg; 2012 Jul; 22(7):1077-83. PubMed ID: 22419108
[TBL] [Abstract][Full Text] [Related]
46. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
47. A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.
Xu B; Yan X; Shao Y; Shen Q; Hua R; Ding R; Yao Q
Obes Surg; 2015 Oct; 25(10):1966-75. PubMed ID: 26254879
[TBL] [Abstract][Full Text] [Related]
48. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
Seyfried F; Miras AD; Rotzinger L; Nordbeck A; Corteville C; Li JV; Schlegel N; Hankir M; Fenske W; Otto C; Jurowich C
Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
[TBL] [Abstract][Full Text] [Related]
49. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
50. Central GLP-1 contributes to improved cognitive function and brain glucose uptake after duodenum-jejunum bypass on obese and diabetic rats.
Ruze R; Xu Q; Liu G; Li Y; Chen W; Cheng Z; Xiong Y; Liu S; Zhang G; Hu S; Yan Z
Am J Physiol Endocrinol Metab; 2021 Sep; 321(3):E392-E409. PubMed ID: 34370593
[TBL] [Abstract][Full Text] [Related]
51. The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery.
Hindsø M; Hedbäck N; Svane MS; Møller A; Martinussen C; Jørgensen NB; Dirksen C; Gasbjerg LS; Kristiansen VB; Hartmann B; Rosenkilde MM; Holst JJ; Madsbad S; Bojsen-Møller KN
Diabetes; 2023 Mar; 72(3):336-347. PubMed ID: 36478039
[TBL] [Abstract][Full Text] [Related]
52. GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification.
Vetter ML; Wadden TA; Teff KL; Khan ZF; Carvajal R; Ritter S; Moore RH; Chittams JL; Iagnocco A; Murayama K; Korus G; Williams NN; Rickels MR
Diabetes; 2015 Feb; 64(2):434-46. PubMed ID: 25204975
[TBL] [Abstract][Full Text] [Related]
53. Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet.
Wallenius V; Elias E; Elebring E; Haisma B; Casselbrant A; Larraufie P; Spak E; Reimann F; le Roux CW; Docherty NG; Gribble FM; Fändriks L
Gut; 2020 Aug; 69(8):1423-1431. PubMed ID: 31753852
[TBL] [Abstract][Full Text] [Related]
54. Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.
Sun X; Zheng M; Song M; Bai R; Cheng S; Xing Y; Yuan H; Wang P
Int J Clin Exp Pathol; 2014; 7(7):4136-42. PubMed ID: 25120793
[TBL] [Abstract][Full Text] [Related]
55. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
Osto E; Doytcheva P; Corteville C; Bueter M; Dörig C; Stivala S; Buhmann H; Colin S; Rohrer L; Hasballa R; Tailleux A; Wolfrum C; Tona F; Manz J; Vetter D; Spliethoff K; Vanhoutte PM; Landmesser U; Pattou F; Staels B; Matter CM; Lutz TA; Lüscher TF
Circulation; 2015 Mar; 131(10):871-81. PubMed ID: 25673670
[TBL] [Abstract][Full Text] [Related]
56. Effects of Roux-en-Y gastric bypass and ileal transposition surgeries on glucose and lipid metabolism in skeletal muscle and liver.
Pezeshki A; Chelikani PK
Surg Obes Relat Dis; 2014; 10(2):217-28. PubMed ID: 24603111
[TBL] [Abstract][Full Text] [Related]
57. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
[TBL] [Abstract][Full Text] [Related]
58. Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes.
Guarino D; Moriconi D; Mari A; Rebelos E; Colligiani D; Baldi S; Anselmino M; Ferrannini E; Nannipieri M
Diabetologia; 2019 Jan; 62(1):178-186. PubMed ID: 30315341
[TBL] [Abstract][Full Text] [Related]
59. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
[TBL] [Abstract][Full Text] [Related]
60. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
